ARIA Imaging in the era of new therapies
Tiago Gil Oliveira, Braga / Portugal
Meike W. Vernooij, Rotterdam / Netherlands
This comprehensive, case-based session offers a holistic view of Amyloid-Related Imaging Abnormalities (ARIA) in patients receiving anti-amyloid therapies. Dr. Oliveira will begin with clinical insights into ARIA’s underlying mechanisms, risk factors, and management strategies. In the second part, Dr. Vernooij will lead an interactive, imaging-focused segment, presenting MRI protocol recommendations, characteristic imaging findings and severity grading through hands-on case discussions with participants.